HORTENSE NGOE: Open Payments
NPI 1063943611 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 30 payments from 12 companies in 2025. Trend: 2023 $545 · 2024 $563 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 10 | $529 |
| ABBVIE INC. | 8 | $146 |
| MML US, Inc. | 1 | $55 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Boston Scientific Corporation | 1 | $36 |
| Globus Medical, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Averitas Pharma Inc. | 1 | $17 |
Products named: Evoke, QULIPTA, ReActiv8, JOURNAVX, UBRELVY, Symbravo, WaveWriter Alpha Prime 16, Senza.
Industry payments across CO — which companies pay providers there.
